Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

Journal of neuro-oncology - 1 Oct 2016

Fürtjes Gina, Köchling Michaela, Peetz-Dienhart Susanne, Wagner Andrea, Heß Katharina, Hasselblatt Martin, Senner Volker, Stummer Walter, Paulus Werner, Brokinkel Benjamin

Abstract excerpt

In meningiomas, prognostic impact of mutations in the human telomerase reverse transcriptase (hTERT) promoter region was recently shown, while studies of promoter methylation and analyses of hemangiopericytomas are lacking. hTERT promoter methylation was analyzed in 78 meningioma and 38 meningeal hemangiopericytoma samples by methylation-specific polymerase chain reaction (MS-PCR) and compared with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Central Nervous System Neoplasms
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Kaplan-Meier Estimate

Share to Meningeal Neoplasms

Share to Meningioma

Share to Promoter Regions, Genetic

Share to Telomerase

Source

Identifiers

PMID: 27465278
DOI: 10.1007/s11060-016-2226-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.PMID 27465278Read ↗

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.Semantic proximity Read ↗

DNA methylation meningioma biomarkers: attributes and limitationsSemantic proximity Read ↗

TERT promoter mutations in primary and secondary WHO grade III meningiomaSemantic proximity Read ↗

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.Semantic proximity Read ↗

TERT Promoter Mutations and Risk of Recurrence in Meningioma.Semantic proximity Read ↗

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.Semantic proximity Read ↗

Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.Semantic proximity Read ↗

Human TERT Promoter Mutations in Atypical and Anaplastic MeningiomasSemantic proximity Read ↗

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.Semantic proximity Read ↗

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.Semantic proximity Read ↗

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.Semantic proximity Read ↗

Involvement of epimutations in meningioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.